The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 21, 2026
Snapshot (as of Oct 21, 2026): Stryker Corporation (SYK) pays a $3.48 annual dividend ($0.88 quarterly), yielding 1.16% at $304.40/share. Next ex-dividend date 2026-09-30. 16 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.16%
Annual Dividend: $3.48 per share
Payout Ratio: 36.1%
Ex-Dividend Date: 2026-09-30
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 36
Stryker Corporation dividend investors are buying into one of medical technology's most recognizable names, a company built on joint replacement implants, surgical equipment, and neurotechnology devices sold to hospitals in roughly 75 countries. The current yield is 1.26%, with a trailing annual dividend rate of $3.48 per share paid quarterly. The next ex-dividend date is September 30, 2026. SYK's beta of 0.768 points to below-market price swings, which suits investors who want dividend growth without sharp portfolio volatility.
Stryker Corporation pays out 35.3% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low payout leaves substantial room to absorb earnings pressure, and SYK's product portfolio spans essential hospital equipment, from trauma implants to emergency medical devices, categories where demand does not evaporate in a downturn. Stryker Corporation dividend safety faces its most realistic test from the capital intensity of operating across 75 countries with a broad manufacturing and distribution footprint, which can compress margins if costs rise faster than revenue.
Stryker Corporation dividend history shows a CAGR of 11.4% per year from 2011 to 2025. The per-share annual dividend grew from $0.7525 to $3.40 over that window (2026 is a partial year and excluded from the growth calculation). The smallest annual increase in the window was 4.9% in 2025, a step down from the double-digit pace that defined most of the prior decade.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +6.2% | $2.83 (2022) | $3.40 (2025) |
| 5-Year | +7.6% | $2.35 (2020) | $3.40 (2025) |
| 10-Year | +9.2% | $1.42 (2015) | $3.40 (2025) |
SYK fits growth-and-income investors who want a rising dividend stream from a medical technology business, and are willing to accept a low current yield in exchange for that growth rate. The yield sits at 1.26%, classified as low (below 2%), and runs above the 5-year average of 1.1%, so the current entry point offers slightly more income than the historical norm. Sixteen consecutive years of increases and an 11.4% CAGR are the headline strengths. The trade-off is straightforward: the income today is modest, and investors are essentially betting on continued dividend growth to make the position work over time.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-30 | $0.8800 |
| 2026-06-30 | $0.8800 |
| 2026-03-31 | $0.8800 |
| 2025-12-31 | $0.8800 |
| 2025-09-30 | $0.8400 |
| 2025-06-30 | $0.8400 |
| 2025-03-31 | $0.8400 |
| 2024-12-31 | $0.8400 |
| 2024-09-30 | $0.8000 |
| 2024-06-28 | $0.8000 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.6400 |
| 2025 | $3.4000 |
| 2024 | $3.2400 |
| 2023 | $3.0500 |
| 2022 | $2.8350 |
Project income from SYK with the SYK dividend calculator or track your full portfolio with the dividend tracker.